Legal Opinion
Bayer Schera Pharma AG v. Sandoz, Inc.
District Court, S.D. New York
Decided September 28, 2010No. 08 Civ. 03710 (PGG)PublishedCited by 7 opinions
1Opinion of the Court
MEMORANDUM OPINION AND ORDER
PAUL G. GARDEPHE, District Judge.
In this action, Bayer Schera Pharma AG and Bayer Healthcare Pharmaceuticals Inc. (collectively “Bayer”) allege that Defendants’ proposed marketing of generic versions of Bayer’s brand-name oral contraceptive Yasmin will infringe on Bayer’s patent rights. Bayer initiated this litigation after Defendants Watson Pharmaceuticals, Inc. and Watson Laboratories, Inc. (collectively ‘Watson”), and Defendant Sandoz, Inc. filed Abbreviated New Drug Applications (“ANDAs”) with the U.S. Food and Drug Administration (“FDA”) to market generic…
2Cases cited23 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Neitzke v. WilliamsSupreme Court of the United States · 1989
- Chambers v. Time Warner, Inc.Court of Appeals for the Second Circuit · 2002
- Salahuddin v. CuomoCourt of Appeals for the Second Circuit · 1988
18 more not listed; retrieve them via the Exa API.
3Cited by7 opinions
- Baldessarre v. Monroe-Woodbury Central School DistrictDistrict Court, S.D. New York · 2011
- Piazza v. Florida Union Free School DistrictDistrict Court, S.D. New York · 2011
- BAYER SCHERING PHARMA AG v. Lupin, Ltd.Court of Appeals for the Federal Circuit · 2012
- BAYER SCHERING PHARMA AG v. Sandoz, Inc.District Court, S.D. New York · 2011
- Actavis Laboratories, Fl, Inc. v. United StatesUnited States Court of Federal Claims · 2022
2 more not listed; retrieve them via the Exa API.